Affiliated Hospital of Nantong University
Nantong, Jiangsu, 226000, China
Location status: Recruiting
Location contact
Qiuhong Ji, MD, PhD
CONTACT
Tian Xu, MD, PhD
CONTACT
NCT Number: NCT06935513
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Interested in participating?
Request Info30 year and older
All sexes
Interventional
Not applicable
Nantong, Jiangsu, 226000, China
Location status: Recruiting
Qiuhong Ji, MD, PhD
CONTACT
Tian Xu, MD, PhD
CONTACT
A randomized controlled study was conducted on the application of smart wearable devices in the intervention of high-risk populations for stroke, with a focus on whether the functions of smart wearable devices such as medication reminders, heart rate monitoring, and exercise reminders can effectively benefit the improvement of key risk factors for stroke, especially blood pressure, blood glucose, and blood lipids.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.
Time frame: 6 months
1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.
Time frame: 6 months
Stroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.
Contact information is provided by the study sponsor or research team.
Pengyu Gong, MD
CONTACT
Qiuhong Ji, MD, PhD
CONTACT
Affiliated Hospital of Nantong University
Other
Acronym: AISP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07340580
Behavior, Body Weight
Greenville, South Carolina, United States
View Trial DetailsNCT03892265
Alcohol Drinking, Alcohol Use, Unspecified
Port-au-Prince, West, Haiti
View Trial DetailsNCT03884647
Alzheimer Disease, Arrhythmias, Cardiac
Walnut Creek, California, United States
View Trial DetailsNCT07043166
Body Weight, Bone Diseases
Shanghai, Shanghai Municipality, China
View Trial Details